Two years of qualification
Audited Supplier
In This Store
Frontier Biotech is a research-based, clinical stage pharmaceutical company founded in 2002. The management team have extensive business and development experiences in the US and China pharma/biotech industry. Frontier Biotech leverages China's large patient population, and rapid growing economy and pharmaceutical market, develops innovative pharmaceutical products with worldwide IP protection. Frontier receives MA from CFDA for Albuvirtide for injection, the world's first long-acting fusion inhibitor for treatment of HIV and to be marketed in the near future. We are dedicated in the discovery, development and commercialization of innovative therapeutic products for unmet medical needs and under-served patients.
Year of Establishment: 2002
Total Assets(USD): choose not to disclose
Total Number of Staff: 250 to 299
Main Competitive Advantages: Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Reputation,Quality Service
Other Competitive Advantages: - A innovative brand portfolio - Executive directors are founders, ensuring alignment of executives’ interests - Capital investment in production technologies and capacities - Centre of excellence for product development, regulatory, supply chain and marketing - Empowered medical and marketing management take ownership of the businesses and are responsible for growth in oversea markets
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight June 2024: Globalization on the Go
